DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
VSFAX
Price
$29.61
Change
-$0.10 (-0.34%)
Updated
Jul 31 closing price
Net Assets
170.4M
Interact to see
Advertisement

DFSVX vs VSFAX

DFSVX vs VSFAX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. VSFAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and VSFAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. VSFAX (170M). DFSVX pays higher dividends than VSFAX: DFSVX (1.50) vs VSFAX (0.89). DFSVX was incepted earlier than VSFAX: DFSVX (33 years) vs VSFAX (30 years). VSFAX (1.53) is less costly to investors than DFSVX (0.31). VSFAX is a more actively managed with annual turnover of: 59.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than VSFAX: DFSVX (0) vs VSFAX (1500). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. VSFAX (24.84). DFSVX return over 5 years is better than : 50.66 vs. VSFAX (12.37).
DFSVXVSFAXDFSVX / VSFAX
Total Expense Ratio0.311.1427%
Annual Report Gross Expense Ratio0.311.5320%
Fund Existence33 years30 years-
Gain YTD21.33618.393116%
Front LoadN/A6%-
Min. Initial Investment01500-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B170M11,471%
Annual Yield % from dividends1.500.89168%
Returns for 1 year34.3924.84138%
Returns for 3 years50.3724.70204%
Returns for 5 years50.6612.37410%
Returns for 10 years107.7129.44366%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I